TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data

Cubeddu, R., Murphy, S., Asher, C., Garcia, S., Granada, J., Lindman, B., Don, C., Perez, E., Cavalcante, J., Coylewright, M., Hahn, R., Khalique, O., Genereux, P., Yadav, P., Thourani, V., & Leon, M. (2021). TCT-40 Medication Use and 3-Year Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings From Real-World Claims Data. Journal of the American College of Cardiology, 78(19), B16–B17. https://doi.org/10.1016/j.jacc.2021.09.890
Authors:
Robert J. Cubeddu
Shannon Murphy
Craig R. Asher
Santiago García
Juan F. Granada
Brian R. Lindman
Creighton W. Don
Eduardo Pérez
João L. Cavalcante
Megan Coylewright
Rebecca T. Hahn
Omar Khalique
Philippe Généreux
Pradeep Yadav
Vinod H. Thourani
Martin B. Leon
Affiliated Authors:
Rebecca T. Hahn
Omar Khalique
Publication Type:
Article
Unique ID:
10.1016/j.jacc.2021.09.890
Publication Date:
Data Source:
OpenAlex

Record Created: